API australian pharmaceutical industries limited

symbion

  1. 11,462 Posts.
    lightbulb Created with Sketch. 93
    0847 [Dow Jones] STOCK CALL: UBS says bidding for API (API.AU) "looks serious now" with chance that Sybmion (SYB.AU) could also get involved. Says offer price of A$2.50 is 40% premium to valuation which could gain attention of API's board. "However, we would not rule out a counter bid from SYB as it too looks for solutions for its distribution operations," UBS says. API last A$2.62, stock soared Tuesday afternoon on Dow Jones report that bid would be lobbed after close of trade. (IGP)


 
Add to My Watchlist
What is My Watchlist?
A personalised tool to help users track selected stocks. Delivering real-time notifications on price updates, announcements, and performance stats on each to help make informed investment decisions.

Currently unlisted public company.

arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.